Skip to main content

Aidoc

Category: AI in Healthcare

AI-powered clinical decision-support platform for radiologists and healthcare providers, focusing on medical imaging analysis and triage Aidoc was founded in 2016. The company is led by Elad Walach. Based in New York, United States. Team size: 488. Total funding raised: $230M total (all rounds). Latest round: Series D. Key investors include ["General Catalyst","Square Peg","NVentures","TCV","TLV Partners","AdventHealth","Sutter Health","WellSpan Health"].

Founded
2016
Headquarters
New York, United States
Team size
488
Total funding
$230M total (all rounds)

Value proposition

Accelerates diagnosis of critical conditions, reduces human error, and improves patient outcomes through AI-driven triage and imaging analysis with the most FDA clearances in clinical AI

Products and solutions

["Multi-triage AI solution for life-threatening conditions","CARE foundation model for clinical decision-making","AI tools for stroke, hemorrhage, and acute care scenarios","Rib fracture detection powered by foundation model","Complete stroke AI package including LVO detection"]

Unique value

First FDA Breakthrough Device Designation for multi-triage AI system; most FDA clearances in clinical AI worldwide; foundation model-powered solutions

Target customer

Healthcare providers, radiologists, and hospitals seeking AI solutions for diagnostic imaging and clinical workflow optimization

Industries served

["Radiology","Medical imaging","Hospital systems","Healthtech","Emergency medicine"]

Technology advantage

18+ FDA clearances, partnerships with NVIDIA and AWS for high-performance AI, integration with electronic health records for real-time triage, CARE foundation model technology

How they differentiate

Aidoc differentiates through real-time triage alerts for critical conditions, 18+ FDA clearances (most in clinical AI), seamless PACS integration, and foundation model technology. Competitors focus on specific areas like stroke triage (Viz.ai) or workflow automation (Qure.ai)

Main competitors

["Viz.ai","Qure.ai","Zebra Medical Vision"]

Key partnerships

["NVIDIA (AI compute and model development)","AWS (cloud infrastructure scaling)","AdventHealth (major U.S. deployment)","Sutter Health (clinical AI integration)","WellSpan Health (enterprise AI expansion)"]

Notable customers

["AdventHealth","Sutter Health","WellSpan Health","150+ U.S. health systems"]

Major milestones

["2025: Secured $150M Series E for CARE foundation model","2025: 18+ FDA clearances for conditions including stroke, bleeds, and fractures","2024: Received FDA Breakthrough Device Designation for multi-triage solution","2025: Filed breakthrough FDA submission for foundation model covering double-digit conditions"]

Growth metrics

Deployed in 1,600+ hospitals worldwide, serving 45+ million patients annually, 18+ FDA clearances

Market positioning

Positioned as the comprehensive clinical AI platform with the broadest FDA-cleared solution portfolio in medical imaging, targeting acute care prioritization

Geographic focus

Primarily U.S. and Europe with deployments across 150+ U.S. health systems and 1,600+ hospitals worldwide

Patents and IP

Multiple FDA clearances and proprietary algorithms; specific patent filings not publicly disclosed

About Elad Walach

Co-founder and CEO of Aidoc since 2016; previously worked at Google Israel (2008-2013) on computer vision projects; holds a B.Sc. in Electrical Engineering and Computer Science from Tel Aviv University; served in Israeli Defense Force technology program 'Talpiot' leading AI research projects

Official website: